Business
Press Release Jan 23 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 23, 2021, titled "Zydus Cadila receives final approval from USFDA for Liothyronine Sodium Tablets".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 23, 2021, titled \"Zydus Cadila receives final approval from USFDA for Liothyronine Sodium Tablets\". View Attachment","length":334,"tagName":"div"}]